Evidence map›Paper›PMID 29518063›Full record

ArticleScientia pharmaceutica2018

4-Methyl-2,2-dioxo-1H-2λ⁶,1-benzothiazine-3-carboxylic Acid. Peculiarities of Preparation, Structure, and Biological Properties.

Igor V Ukrainets, Ganna M Hamza, Anna A Burian, Svitlana V Shishkina, Natali I Voloshchuk, Oxana V Malchenko

Open access · goldAbstract read
In one paragraph

Article in Scientia pharmaceutica, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. 3,3'-(Phenyl-methyl-ene)bis-(1-ethyl-3,4-di-hydro-1Acta crystallographica. Section E, Crystallographic communications · 2023
    Article
  2. Article
  3. 2-Amino-4-(4-chloro-1-ethyl-2,2-dioxo-1Acta crystallographica. Section E, Crystallographic communications · 2021
    Article
  4. Mol-ecular and crystal structure of methyl 4-methyl-2,2-dioxo-1Acta crystallographica. Section E, Crystallographic communications · 2018
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Igor V UkrainetsDepartment of Pharmaceutical Chemistry, National University of Pharmacy, 53 Pushkinska st., 61002 Kharkiv, Ukraine. igor.v.ukrainets@gmail.com.
Ganna M HamzaDepartment of Pharmaceutical Chemistry, National University of Pharmacy, 53 Pushkinska st., 61002 Kharkiv, Ukraine. annahamza@ukr.net.
Anna A BurianDepartment of Pharmaceutical Chemistry, National University of Pharmacy, 53 Pushkinska st., 61002 Kharkiv, Ukraine. anna_chem@ukr.net.
Svitlana V ShishkinaSTC "Institute for Single Crystals", National Academy of Sciences of Ukraine, 60 Nauki ave., 61001 Kharkiv, Ukraine. sveta@xray.isc.kharkov.com.
Natali I VoloshchukDepartment of Pharmacology, N. I. Pirogov Vinnitsa National Medical University, 56 Pirogov st., 21018 Vinnitsa, Ukraine. voloshchuknatali@gmail.com.ORCID 0000-0002-0166-9676
Oxana V MalchenkoDepartment of Pharmacology, N. I. Pirogov Vinnitsa National Medical University, 56 Pirogov st., 21018 Vinnitsa, Ukraine. malchenko2576@gmail.com.
National University of Pharmacy · UANational Pirogov Memorial Medical University, Vinnytsya · UANational Academy of Sciences of Ukraine · UA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In order to determine the regularities of the structure-analgesic activity relationship, the peculiarities of obtaining, the spatial structure, and biological properties of 4-methyl-2,2-dioxo-1

Indexed as

2,1-benzothiazine4-methyl-2,2-dioxo-1H-2λ6,1-benzothiazine-3-carboxylic acidanalgesic activityanti-inflammatory actioncrystal structureestershydrolysis

Identifiers

PMID29518063
PMCPMC5874539
OpenAlexW2790751853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.